Business Context and Reporting Period
This Form 6-K filing by Gold Fields Limited (GFI) covers the month of September 2010. The report discloses a material corporate action regarding executive compensation, specifically the acceptance of equity awards granted on March 1, 2010, by two directors. The filing was signed on September 15, 2010, by Mr. W J Jacobsz, Senior Vice President of Investor Relations and Corporate Affairs.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of securities dealings and does not contain financial performance data for the period.
Material Changes and Executive Compensation
The primary material change disclosed is the formal acceptance of Share Appreciation Rights (SARS) and Performance Vesting Restricted Shares (PVRS) by two directors. These awards were originally granted on March 1, 2010, and accepted on September 15, 2010.
- PA Schmidt (Director):
- 22,350 SARS granted with a strike price of R89.76.
- 26,250 PVRS granted with a nil strike price.
- MD Fleischer (Director):
- 22,350 SARS granted with a strike price of R89.76.
- 25,575 PVRS granted with a nil strike price.
Both awards vest on the third anniversary of the grant date. The PVRS settlement is contingent on performance criteria measured over three years, based on the company's expected gold production and relative peer group performance, with potential settlement increases of up to 300%.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the standard performance conditions attached to the PVRS awards. The document confirms that necessary clearance was obtained in accordance with JSE Listings Requirements.
Investor Verification Checklist
- Verify the current fair market value of Gold Fields shares to assess the potential value of the SARS granted at a strike price of R89.76.
- Review the specific gold production targets and peer group performance metrics required for the PVRS settlement.
- Confirm the vesting schedule and exercise window (three years post-vesting) for the granted SARS.
- Check subsequent filings for any changes in the directors' beneficial ownership or additional equity grants.